Cargando…
Benefits of sacubitril/valsartan use in patients with chronic heart failure after cardiac valve surgery: a single-center retrospective study
OBJECTIVES: To evaluate the efficacy of sacubitril/valsartan for the treatment of patients with chronic heart failure (CHF) after cardiac valve surgery (CVS). METHODS: Data were collected from 259 patients who underwent CVS due to valvular heart disease and were admitted to the hospital with CHF fro...
Autores principales: | Zheng, Jian, Wu, Qingsong, Li, Qianzhen, Tang, Mirong, He, Jian, Qiu, Zhihuang, Xie, Linfeng, Chen, Liangwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091567/ https://www.ncbi.nlm.nih.gov/pubmed/37041595 http://dx.doi.org/10.1186/s13019-023-02252-y |
Ejemplares similares
-
A new procedure for elimination of atrial fibrillation associated with mitral valve disease: a proof-of-concept study
por: Chen, Liangwan, et al.
Publicado: (2023) -
Sacubitril–valsartan in heart failure and multimorbidity patients
por: Rodil Fraile, Raquel, et al.
Publicado: (2018) -
Assessing clinical and biomarker characteristics to optimize the benefits of sacubitril/valsartan in heart failure
por: Litwin, Sheldon E., et al.
Publicado: (2022) -
Practical guidance on the use of sacubitril/valsartan for heart failure
por: Sauer, Andrew J., et al.
Publicado: (2018) -
Effectiveness of sacubitril–valsartan in cancer patients with heart failure
por: Martín‐Garcia, Ana, et al.
Publicado: (2020)